Viewing Study NCT03376659


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-03-09 @ 7:06 AM
Study NCT ID: NCT03376659
Status: TERMINATED
Last Update Posted: 2024-02-05
First Post: 2017-11-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
Sponsor: Georgetown University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2017-1189
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None NIH View
None OTHER View
None OTHER View
None INDUSTRY View
None OTHER View
None INDUSTRY View